Welcome!

News Feed Item

Cell Surface Markers (Flow Cytometers, Hematology Analyzers, Reagents And Kits) Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2018

LONDON, Jan. 6, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:

Cell Surface Markers (Flow Cytometers, Hematology Analyzers, Reagents And Kits) Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2018

The cell surface markers market is undergoing impressive growth across the globe due to rapid automation of technologies and solutions, simplification of data management coupled with increasing preference for reduction of healthcare spending with a view to provide rapid and efficient decision making for therapies for specific diseases. On the other hand, high prevalence of chronic diseases such as cancer and autoimmune disorders has resulted in an elevated demand for cell surface markers analysis worldwide. Since their introduction, cell surface makers study has undergone tremendous technological development, and it is expected that soon end-users will be benefited from the increasing scope of applications of cell surface markers.

This report studies the cell surface markers market by the types of products commercially available for cell markers analysis. Each of the segments has been analyzed on the basis of its current and future market size for the period 2011 to 2019, in terms of revenue generation in USD million. The CAGR (%) of all segments has been provided for the forecast period of 2013 to 2019, considering 2012 as the base year.

In terms of geography, this market has been classified into North America, Europe, Asia-Pacific and Rest of the World (RoW) regions. The respective market size for each region and their forecast till 2019 has also been presented in the report. In addition, a qualitative assessment of the market dynamics of the cell surface markers market has been provided, wherein the drivers, restraints, opportunities and market attractiveness has been studied.

The competitive landscape section of this report provides a bird's eye view of the major market players currently operating in this market and their respective products. Also, a pipeline snapshot of new entrants in this market along with their development stage products has been included. Some of the key market players profiled in this report include Abbott Laboratories, Inc., Beckman Coulter, Inc., BD Biosciences, Bio-Rad Laboratories, Inc., Grifols SA, Immucor, Inc. and Janssen Diagnostics, Inc.

Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.4 List of Abbreviations

Chapter 2 Executive Summary

Chapter 3 Market Overview
3.1 Market Trends and Future Outlook
3.2 Global Cell Surface Markers Market Revenues, by Instruments and Reagents, 2011 – 2019 (USD Million)
3.3 Drivers
3.3.1 Growing Automation in Laboratories
3.3.2 Discovery of New Markers will Need New Antibodies
3.3.3 Increased Use of In Vitro Diagnostics
3.3.4 Need for Lowering Healthcare Expenditure
3.4 Restraints
3.4.1 Reluctance for High Investment in Sophisticated Models
3.4.2 Complexity in the Use of Flow Cytometers
3.5 Opportunities
3.5.1 Growth in Expertise for Operation of Cell Marking Tools
3.5.2 Targeted Therapy and Personalized Medicine
3.6 Porter's Five Force Analysis for the Global Cell Surface Markers Market
3.6.1 Bargaining Power of Suppliers
3.6.2 Bargaining Power of Buyers
3.6.3 Threat of New Entrants
3.6.4 Threat of Substitutes
3.6.5 Competitive Rivalry
3.7 Market Attractiveness Analysis of Global Cell Surface Markers Market, by Instruments and Reagents, 2012

Chapter 4 Global Cell Surface Markers Market, by Instruments and Reagents
4.1 Overview – Current Market Scenario and Future Market Trends
4.1.1 Global Cell Surface Markers Market Revenues, 2011 – 2019 (USD Million)
4.2 Flow Cytometry
4.2.1 Global Flow Cytometers Market Revenues, 2013 – 2019 (USD Million)
4.2.2 Global Flow Cytometers Market Volume, 2013 – 2019 (Number of Units Installed)
4.3 Hematology Analyzers
4.3.1 Global Hematology Analyzers Market Revenues, 2011 – 2019 (USD Million)
4.3.2 Global Hematology Analyzers Market Volume, 2013 – 2019 (Number of Units Installed)
4.4 Reagents and Kits
4.4.1 Global Reagent and Kits Market Revenues, 2011 – 2019 (USD Million)

Chapter 5 Global Cell Surface Markers Market, by Applications
5.1 Disease Diagnosis
5.1.1 Global Cell Surface Markers Market Revenues, by Disease Diagnosis and Identification, 2011 – 2019 (USD Million)
5.2 Research and Drug Discovery
5.2.1 Global Cell Surface Markers Market Revenues, by Research and Drug Discovery, 2011 – 2019 (USD Million)

Chapter 6 Global Cell Surface Markers Market, by Geography
6.1 Introduction
6.2 North America
6.2.1 North America Cell Surface Markers Market Revenues, 2011 – 2019 (USD Million)
6.3 Europe
6.3.1 Europe Cell Surface Markers Market Revenues, Size and Forecast, 2011 – 2019 (USD Million)
6.4 Asia-Pacific
6.4.1 Asia-Pacific Cell Surface Markers Market Revenues, 2011 – 2019 (USD Million)
6.5 Rest of the World (RoW)
6.5.1 Rest of the World (RoW) Cell Surface Markers Market Revenues, Size and Forecast, 2011 – 2019 (USD Million)

Chapter 7 Recommendations

Chapter 8 Company Profiles
8.1 Abbott Laboratories, Inc.
8.1.1 Company Overview
8.1.2 Strategic Overview
8.1.3 Financial Overview
8.1.4 Product Portfolio
8.1.5 Recent Developments
8.2 Beckman Coulter, Inc.
8.2.1 Company Overview
8.2.2 Strategic Overview
8.2.3 Financial Overview
8.2.4 Product Portfolio
8.2.5 Recent Developments
8.3 BD Biosciences
8.3.1 Company Overview
8.3.2 Strategic Overview
8.3.3 Financial Overview
8.3.4 Product Portfolio
8.3.5 Recent Development
8.4 Bio-Rad Laboratories, Inc.
8.4.1 Company Overview
8.4.2 Strategic Overview
8.4.3 Financial Overview
8.4.4 Product Portfolio
8.4.5 Recent Development
8.5 Grifols SA
8.5.1 Company Overview
8.5.2 Strategic Overview
8.5.3 Financial Overview
8.5.4 Product Portfolio
8.5.5 Recent Development
8.6 Immucor, Inc.
8.6.1 Company Overview
8.6.2 Strategic Overview
8.6.3 Financial Overview
8.6.4 Product Portfolio
8.6.5 Recent Developments
8.7 Janssen Diagnostics, Inc.
8.7.1 Company Overview
8.7.2 Strategic Overview
8.7.3 Financial Overview
8.7.4 Product Portfolio
8.7.5 Recent development
8.8 Nihon Kohden Corporation
8.8.1 Company Overview
8.8.2 Strategic Overview
8.8.3 Financial Overview
8.8.4 Product Portfolio
8.8.5 Recent developments
8.9 F. Hoffmann-La Roche Ltd.
8.9.1 Company Overview
8.9.2 Strategic Overview
8.9.3 Financial Overview
8.9.4 Product Portfolio
8.9.5 Recent Developments
8.10 Siemens Healthcare
8.10.1 Company Overview
8.10.2 Strategic Overview
8.10.3 Financial Overview
8.10.4 Product Portfolio
8.10.5 Recent Developments
8.11 Sysmex Corporation
8.11.1 Company Overview
8.11.2 Strategic Overview
8.11.3 Financial Overview
8.11.4 Product Portfolio
8.11.5 Recent Development
8.12 Thermo Fischer Scientific, Inc.
8.12.1 Company Overview
8.12.2 Strategic Overview
8.12.3 Financial Overview
8.12.4 Product Portfolio
8.12.5 Recent Development

LIST OF FIGURES

FIG. 1 Cell Surface Markers: Market Segmentation
FIG. 2 Global Cell Surface Markers Market Revenues, by Instruments and Reagents, 2012 (USD Million)
FIG. 3 Global Cell Surface Markers Market Revenues, by Geography, 2012 (USD Million)
FIG. 4 Porter's Five Force Analysis: Global Cell Surface Markers Market
FIG. 5 Market Attractive Analysis: Global Cell Surface Markers Market, by Instruments and Reagents, 2012
FIG. 6 Global Cell Surface Markers Market Revenues, 2011 – 2019 (USD Million)
FIG. 7 Global Flow Cytometers Market Revenues, 2011 - 2019 (USD Million)
FIG. 8 Global Flow Cytometers Market Volume, 2011 – 2019 (Number of Units Installed)
FIG. 9 Global Hematology Analyzers Market Revenues, 2011 - 2019 (USD Million)
FIG. 10 Global Hematology Analyzers Market Volume, 2011 – 2019 (Number of Units Installed)
FIG. 11 Global Reagents and Kits Market Revenues, 2011 - 2019 (USD Million)
FIG. 12 Global Cell Surface Markers Market Revenues, by Disease Diagnosis and Identification, 2011 - 2019 (USD Million)
FIG. 13 Global Cell Surface Markers Market Revenues, by Research and Drug Discovery, 2011 - 2019 (USD Million)
FIG. 14 North America Cell Surface Markers Market Revenues, 2011 - 2019 (USD Million)
FIG. 15 Europe Cell Surface Markers Market Revenues, 2011 - 2019 (USD Million)
FIG. 16 Asia-Pacific Cell Surface Markers Market Revenues, 2011 - 2019(USD Million)
FIG. 17 Rest of the World (RoW) Cell Surface Markers Market Revenues, 2011 - 2019 (USD Million)
FIG. 18 Annual Revenues of Abbott Laboratories, Inc., 2010 – 2012 (USD Million)
FIG. 19 Annual Revenues of Bio-Rad Laboratories, Inc., 2010 – 2012 (USD Million)
FIG. 20 Annual Revenues of Grifols SA, 2010 – 2012 (USD Million)
FIG. 21 Annual Revenues of Immucor, Inc., 2010 – 2012 (USD Million)
FIG. 22 Annual Revenues of Nihon Kohden Corp., 2010 – 2012 (USD Million)
FIG. 23 Annual Revenues of Hoffmann-La Roche Ltd., 2010 – 2012 (USD Million)
FIG. 24 Annual Revenues of Siemens Healthcare, 2010 – 2012 (USD Million)
+FIG. 25 Annual Revenues of Sysmex Corporation, 2010 – 2012 (USD Million)
FIG. 26 Annual Revenues of Thermo Fischer Scientific, Inc., 2010 – 2012 (USD Million)

LIST OF TABLES

TABLE 1 Market Snapshot: Global Cell Surface Markers Market
TABLE 2 Global Cell Surface Markers Market Revenues, by Instruments and Reagents, 2011 – 2019 (USD Million)
TABLE 3 Global Cell Surface Markers Market Revenues, by Geography, Size and Forecast, 2013-2019 (USD Million)
TABLE 4 North America Cell Surface Markers Market Revenues, by Instruments and Reagents, 2011 – 2019 (USD Million)
TABLE 5 Europe Cell Surface Markers Market Revenues, By Instruments and Reagents, 2011 – 2019 (USD Million)
TABLE 6 Asia-Pacific Cell Surface Markers Market Revenues, By Instruments and Reagents, 2011 – 2019 (USD Million)
TABLE 7 RoW Cell Surface Markers Market Revenues, By Instruments and Reagents, 2011 – 2019 (USD Million)

Read the full report:
Cell Surface Markers (Flow Cytometers, Hematology Analyzers, Reagents And Kits) Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2018
http://www.reportbuyer.com/pharma_healthcare/diagnostics/cell_surface_markers_flow_cytometers_hematology_analyzers_reagents_kits_market_global_industry_analysis_size_share_growth_trends_forecast_2012_2018.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]  
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
The emerging Internet of Everything creates tremendous new opportunities for customer engagement and business model innovation. However, enterprises must overcome a number of critical challenges to bring these new solutions to market. In his session at @ThingsExpo, Michael Martin, CTO/CIO at nfrastructure, outlined these key challenges and recommended approaches for overcoming them to achieve speed and agility in the design, development and implementation of Internet of Everything solutions with...
In their general session at 16th Cloud Expo, Michael Piccininni, Global Account Manager - Cloud SP at EMC Corporation, and Mike Dietze, Regional Director at Windstream Hosted Solutions, reviewed next generation cloud services, including the Windstream-EMC Tier Storage solutions, and discussed how to increase efficiencies, improve service delivery and enhance corporate cloud solution development. Michael Piccininni is Global Account Manager – Cloud SP at EMC Corporation. He has been engaged in t...
Cloud Expo, Inc. has announced today that Andi Mann returns to 'DevOps at Cloud Expo 2017' as Conference Chair The @DevOpsSummit at Cloud Expo will take place on June 6-8, 2017, at the Javits Center in New York City, NY. "DevOps is set to be one of the most profound disruptions to hit IT in decades," said Andi Mann. "It is a natural extension of cloud computing, and I have seen both firsthand and in independent research the fantastic results DevOps delivers. So I am excited to help the great t...
Every successful software product evolves from an idea to an enterprise system. Notably, the same way is passed by the product owner's company. In his session at 20th Cloud Expo, Oleg Lola, CEO of MobiDev, will provide a generalized overview of the evolution of a software product, the product owner, the needs that arise at various stages of this process, and the value brought by a software development partner to the product owner as a response to these needs.
In 2014, Amazon announced a new form of compute called Lambda. We didn't know it at the time, but this represented a fundamental shift in what we expect from cloud computing. Now, all of the major cloud computing vendors want to take part in this disruptive technology. In his session at 20th Cloud Expo, John Jelinek IV, a web developer at Linux Academy, will discuss why major players like AWS, Microsoft Azure, IBM Bluemix, and Google Cloud Platform are all trying to sidestep VMs and containers...
SYS-CON Events announced today that MobiDev, a client-oriented software development company, will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place June 6-8, 2017, at the Javits Center in New York City, NY, and the 21st International Cloud Expo®, which will take place October 31-November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. MobiDev is a software company that develops and delivers turn-key mobile apps, websites, web services, and complex softw...
SYS-CON Events announced today that Enzu will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY, and the 21st International Cloud Expo®, which will take place October 31-November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Enzu’s mission is to be the leading provider of enterprise cloud solutions worldwide. Enzu enables online businesses to use its IT infrastructure to their competitive ad...
Smart Cities are here to stay, but for their promise to be delivered, the data they produce must not be put in new siloes. In his session at @ThingsExpo, Mathias Herberts, Co-founder and CTO of Cityzen Data, discussed the best practices that will ensure a successful smart city journey.
In his session at 19th Cloud Expo, Claude Remillard, Principal Program Manager in Developer Division at Microsoft, contrasted how his team used config as code and immutable patterns for continuous delivery of microservices and apps to the cloud. He showed how the immutable patterns helps developers do away with most of the complexity of config as code-enabling scenarios such as rollback, zero downtime upgrades with far greater simplicity. He also demoed building immutable pipelines in the cloud ...
Traditional on-premises data centers have long been the domain of modern data platforms like Apache Hadoop, meaning companies who build their business on public cloud were challenged to run Big Data processing and analytics at scale. But recent advancements in Hadoop performance, security, and most importantly cloud-native integrations, are giving organizations the ability to truly gain value from all their data. In his session at 19th Cloud Expo, David Tishgart, Director of Product Marketing ...
Choosing the right cloud for your workloads is a balancing act that can cost your organization time, money and aggravation - unless you get it right the first time. Economics, speed, performance, accessibility, administrative needs and security all play a vital role in dictating your approach to the cloud. Without knowing the right questions to ask, you could wind up paying for capacity you'll never need or underestimating the resources required to run your applications.
Technology vendors and analysts are eager to paint a rosy picture of how wonderful IoT is and why your deployment will be great with the use of their products and services. While it is easy to showcase successful IoT solutions, identifying IoT systems that missed the mark or failed can often provide more in the way of key lessons learned. In his session at @ThingsExpo, Peter Vanderminden, Principal Industry Analyst for IoT & Digital Supply Chain to Flatiron Strategies, will focus on how IoT depl...
Adding public cloud resources to an existing application can be a daunting process. The tools that you currently use to manage the software and hardware outside the cloud aren’t always the best tools to efficiently grow into the cloud. All of the major configuration management tools have cloud orchestration plugins that can be leveraged, but there are also cloud-native tools that can dramatically improve the efficiency of managing your application lifecycle. In his session at 18th Cloud Expo, ...
The pace of innovation, vendor lock-in, production sustainability, cost-effectiveness, and managing risk… In his session at 18th Cloud Expo, Dan Choquette, Founder of RackN, discussed how CIOs are challenged finding the balance of finding the right tools, technology and operational model that serves the business the best. He also discussed how clouds, open source software and infrastructure solutions have benefits but also drawbacks and how workload and operational portability between vendors an...
With the proliferation of both SQL and NoSQL databases, organizations can now target specific fit-for-purpose database tools for their different application needs regarding scalability, ease of use, ACID support, etc. Platform as a Service offerings make this even easier now, enabling developers to roll out their own database infrastructure in minutes with minimal management overhead. However, this same amount of flexibility also comes with the challenges of picking the right tool, on the right ...